반응식
[NH2:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[SH:9].[C:10]([O:14][C:15](=[O:24])[NH:16][C:17]1[S:18][CH:19]=[C:20]([CH2:22]Cl)[N:21]=1)([CH3:13])([CH3:12])[CH3:11].C([O-])([O-])=O.[K+].[K+]>CN(C=O)C>[C:10]([O:14][C:15](=[O:24])[NH:16][C:17]1[S:18][CH:19]=[C:20]([CH2:22][S:9][C:3]2[CH:4]=[CH:5][C:6]([Cl:8])=[CH:7][C:2]=2[NH2:1])[N:21]=1)([CH3:13])([CH3:12])[CH3:11]참가 물질
5
실험 절차
Following General Procedure A, the title compound (588 mg, 67%) was prepared from 2-amino-4-chlorobenzenethiol (376 mg, 2.36 mmol), tert-butyl[4-(chloromethyl)-1,3-thiazol-2-yl]carbamate (391 mg, 1.57 mmol) and K2CO3 (1.08 g, 3.45 mmol) in DMF (10 ml).
출처 및 근거
- ORD 기록
- ord-e72513c4eeff49dab5427de8cdb6af54
- 출처 데이터셋
- uspto-grants-2014_07
- 특허 번호
- US08791161B2
연결된 노트
불러오는 중…